Search Results | Clinicalinfo

Search Results 61 – 80 of 84

… of Washington or the New York State Department of Health . HIV-2 resistance may occur with INSTIs, NRTIs, or … less infectious than HIV-1, with a fivefold lower rate of sexual transmission and a 20-fold to 30-fold lower rate of … . Kanki PJ, Travers KU, S MB, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet . …

https://clinicalinfo.hiv.gov/node/11268

Special Populations: HIV-2 Infection

… treating people of West African origin, people who have had sexual contact with or shared needles with people of West … United Nations Programme on HIV and AIDS nor the World Health Organization has formal surveillance systems for … ART likely provides a reduced risk of transmission to sexual partners. 53-55 Viral mutations that are associated …

https://clinicalinfo.hiv.gov/node/9288

Cytomegalovirus Disease

… status, and race or ethnicity. 1 In the U.S. National Health and Nutrition Examination Survey 1999–2004, overall … several ways, including through breastfeeding, perinatally, sexually, viral shedding in bodily fluids (saliva, urine, or … to CMV among adults with HIV, but condoms may reduce sexual transmission of CMV. 31,32 Preventing Disease …

https://clinicalinfo.hiv.gov/node/9174

Early (Acute and Recent) HIV Infection

… Pregnancy , Appendix C: Antiretroviral Counseling Guide for Health Care Providers , and Early (Acute and Recent) HIV … behaviors are not reported, it is still possible that sexual partners are practicing high-risk behaviors privately … INSTI resistance in pregnancies with early infection when sexual partners are on INSTI-based ART and have unsuppressed …

https://clinicalinfo.hiv.gov/node/11264

Treatment Goals

… mortality at all clinical stages of HIV 1-‍5 and reduces sexual and perinatal HIV transmission to others. 6-11 In … and archival of drug-resistance mutations, and prevents sexual and perinatal transmission of HIV, all of which are … individual circumstances (e.g., substance use, mental health conditions, adverse effects), and structural barriers …

https://clinicalinfo.hiv.gov/node/9416

Diagnosis of HIV Infection in Infants and Children

… maternal HIV during breastfeeding, premasticated feeding, sexual abuse, contaminated blood products, percutaneous … HIV diagnosed during breastfeeding, premasticated feeding, sexual abuse, contaminated blood products, percutaneous … maternal HIV infection during breastfeeding should prompt health care professionals to counsel to discontinue …

https://clinicalinfo.hiv.gov/node/9222

General Terms

… disorder of pregnancy HDV hepatitis D virus HRSA Health Resources and Services Administration HSR … NICHD Eunice Kennedy Shriver National Institute of Child Health and Human Development NIH National Institutes of … membranes SGA small for gestational age SQ subcutaneous STI sexually transmitted infection SVR12 sustained virologic …

https://clinicalinfo.hiv.gov/node/11931

General Terms

… HgbA1c glycosylated hemoglobin HHS U.S. Department of Health and Human Services HIV RNA or HIV-1 RNA viral load … SD standard deviation SJS Stevens-Johnson syndrome SMR sexual maturity rating SMS short message service SOC standard of care SQ subcutaneous STI sexually transmitted infection STR single-tablet regimen T ½ …

https://clinicalinfo.hiv.gov/node/9212

Lamivudine

… Weight-band dosing in the table above is derived from World Health Organization recommendations. These doses result in … at: https://pubmed.ncbi.nlm.nih.gov/22180560 . World Health Organization. Annex 3. Dosages of ARV drugs for … an empty stomach Symfi Lo has not been studied in children (sexual maturity ratings [SMRs] 1–3), and major …

https://clinicalinfo.hiv.gov/node/9284

Appendix A. Key to Acronyms

… virus HEU HIV-exposed but uninfected HHS U.S. Department of Health and Human Services HHV-8 human herpesvirus-8 Hib … intraepithelial lesion SJS Stevens-Johnson Syndrome SMR sexual maturity rating SQ subcutaneous STD sexually transmitted disease SVR sustained virologic …

https://clinicalinfo.hiv.gov/node/12766

HIV Clinical Guidelines Now Recommend High Resolution Anoscopy as Part of Anal Cancer Screening Program for People with HIV

… the National Cancer Institute at the National Institutes of Health (NIH), which found that the use of HRA helped prevent … recommendations. Human papillomavirus (HPV) is a common sexually transmitted infection. For people with HIV, … not yet available everywhere. Panel: The U.S. Department of Health and Human Services’ (HHS) Panel on the Prevention and …

https://clinicalinfo.hiv.gov/node/13471

Cytomegalovirus

… when sanitary conditions are suboptimal. Among adolescents, sexual transmission is the major mode of CMV acquisition. … child-rearing practices, crowding, sanitation, and sexual behavior most likely influence age-related variations … Institute of Standards and Technology and the World Health Organization Expert Committee on Biological …

https://clinicalinfo.hiv.gov/node/9391

Previous Experience With Antiretroviral Medications but Not Currently on Antiretroviral Therapy During Current Pregnancy

… resistance assays and other test results. Even experienced health care providers may have difficulty selecting … to the infant (i.e., perinatal prevention) or the sexual partner. ARV drugs may also have been taken … for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational …

https://clinicalinfo.hiv.gov/node/11891

Candidiasis (Mucocutaneous)

… a single episode or recurrent—is common in healthy adults and does not suggest HIV. Clinical … for other potential pathogens including those that cause sexually transmitted infections (STIs). Preventing Exposure … for the 2021 Centers for Disease Control and Prevention of sexually transmitted Infections treatment guidelines. Clin …

https://clinicalinfo.hiv.gov/node/9314

National Youth HIV/AIDS Awareness Day

… to ensure youth have tools to prevent HIV and other sexually transmitted infections (STIs). The National Institutes of Health (NIH) HIV research program, coordinated by the NIH …

https://clinicalinfo.hiv.gov/news/el-dia-nacional-de-concientizacion-sobre-el-vih-y-el-sida-en-jovenes

HIV and Opportunistic Infections, Coinfections, and Conditions

… in people with weakened immune systems than in people with healthy immune systems. People with weakened immune systems … ? HIV and Hepatitis B HIV and Tuberculosis (TB) HIV and Sexually Transmitted Diseases (STDs) HIV and Heart Disease …

https://clinicalinfo.hiv.gov/news/vih-e-infecciones-oportunistas-coinfecciones-y-condiciones

Diagnosis of HIV Infection in Infants and Children

https://clinicalinfo.hiv.gov/node/9403

Table 1. Chemoprophylaxis to Prevent First Episode of Opportunistic Disease

… anti-TB drugs after consultation with experts and public health authorities (AIII). Pneumocystis Pneumonia (PCP) … primary, secondary, or early latent syphilis. Individuals sexually exposed ≤90 days before the partner’s diagnosis … regardless of syphilis serologic status (AII). Individuals sexually exposed >90 days before the partner’s diagnosis …

https://clinicalinfo.hiv.gov/node/9410

Appendix A, Table 2. Antiretroviral Fixed-Dose Combination Tablets: Minimum Body Weights and Considerations for Use in Children and Adolescents

… renal toxicity. TDF is not recommended for children with sexual maturity ratings of 1 to 3 because of TDF-associated … and Appendix C: Antiretroviral Counseling Guide for Health Care Providers ). b Minimum body weight and age are … inhibitor; RPV = rilpivirine; RTV = ritonavir; SMR = sexual maturity rating; TAF = tenofovir alafenamide; TDF = …

https://clinicalinfo.hiv.gov/node/9422

What to Start: Antiretroviral Treatment Regimens Recommended for Initial Therapy in Infants and Children With HIV

… chronic treatment for any other conditions (e.g., mental health conditions, seizure disorders, tuberculosis)? If so, … for prepubertal children and adolescents (i.e., those with sexual maturity ratings [SMR] of 1 to 3). 1 The Adult and … changes in body composition, and development of secondary sexual characteristics. It is recognized that these changes …

https://clinicalinfo.hiv.gov/node/13576